McKesson Corporation (MCK) income statement
NYSE · Healthcare · Medical - Distribution · 42,300 employees · CEO Brian S. Tyler
- Price
- $994.58 +1.40%
- Market cap
- $116B
- Enterprise value
- $122B
- Last report
- Q1 '27 filed 2026-08-05
- Next report
- 2026-11-04 EPS est. $10.72
McKesson Corporation (MCK) reported revenue of $105B for Q1 '27 (+7.7% year on year), operating income of $1.32B (1.3% of revenue) and net income of $614M. Over the last four quarters revenue was $411B.
Income statement
| Income statement | Trend | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $77.2B | $80.9B | $76.4B | $79.3B | $93.7B | $95.3B | $90.8B | $97.8B | $103B | $106B | $96.3B | $105B | |
| Cost of revenue | $74.3B | $77.9B | $72.9B | $76.3B | $90.5B | $92.1B | $87.9B | $94.5B | $99.6B | $102B | $92.3B | $102B | |
| Gross profit | $2.9B | $3.03B | $3.46B | $2.96B | $3.15B | $3.22B | $2.92B | $3.28B | $3.54B | $3.69B | $4.04B | $3.69B | |
| Sales & marketing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.2B | $2.07B | -$2.03B | $0 | $0 | |
| Other operating expenses | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $47M | $0 | $4.1B | $0 | $102M | |
| Operating expenses | $2B | $2.41B | $2.09B | $1.9B | $2.4B | $1.93B | $1.88B | $2.24B | $2.07B | $2.07B | $1.8B | $2.37B | |
| Operating income | $898M | $623M | $1.37B | $1.06B | $745M | $1.29B | $1.04B | $1.04B | $1.47B | $1.62B | $2.25B | $1.32B | |
| Interest expense | $61M | $64M | $80M | $66M | $78M | $67M | $45M | $49M | $74M | $63M | -$61M | $77M | |
| Other non-operating income (gains on investments, FX ...) | -$79M | -$53M | $122M | -$89M | $133M | -$6M | -$524M | -$64M | -$1M | -$36M | $184M | -$66M | |
| Total non-operating income | $18M | -$11M | -$202M | $23M | -$211M | -$61M | $479M | $15M | -$73M | $11M | -$123M | -$11M | |
| Income before tax | $916M | $612M | $1.17B | $1.08B | $534M | $1.23B | $1.52B | $1.05B | $1.4B | $1.63B | $2.13B | $1.31B | |
| Income tax | $213M | -$18M | $340M | $124M | $247M | $298M | $209M | $220M | $232M | $380M | $270M | $276M | |
| Net income | $664M | $589M | $791M | $915M | $241M | $879M | $1.26B | $784M | $1.11B | $1.19B | $1.68B | $614M | |
| EPS (basic) | $4.95 | $4.45 | $6.05 | $7.05 | $1.87 | $6.98 | $10.06 | $6.28 | $8.95 | $9.63 | $13.78 | $5.17 | |
| EPS (diluted) | $4.93 | $4.42 | $6.01 | $7.00 | $1.86 | $6.94 | $10.01 | $6.25 | $8.92 | $9.59 | $13.71 | $5.15 | |
| Shares (basic, weighted) | 134M | 133M | 131M | 130M | 129M | 126M | 125M | 125M | 124M | 123M | 122M | 119M | |
| Shares (diluted, weighted) | 135M | 133M | 132M | 131M | 129M | 127M | 126M | 126M | 124M | 124M | 123M | 119M | |
| Depreciation & amortization | $157M | $159M | $160M | $169M | $163M | $153M | $151M | $157M | $188M | $188M | $196M | $195M | |
| EBITDA | $1.13B | $835M | $1.41B | $1.32B | $775M | $1.45B | $1.71B | $1.26B | $1.66B | $1.84B | $2.26B | $1.58B |
| Income statement | Trend | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $199B | $208B | $214B | $231B | $238B | $264B | $277B | $309B | $359B | $403B | |
| Cost of revenue | $188B | $198B | $204B | $220B | $227B | $251B | $265B | $297B | $347B | $389B | |
| Gross profit | $10.7B | $10.4B | $10.8B | $11.4B | $11.6B | $12.6B | $11.9B | $12.2B | $12.5B | $14.6B | |
| Research & development | $341M | $125M | $71M | $96M | $74M | $70M | $89M | $77M | $91M | $103M | |
| Sales & marketing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$8.1B | |
| Other operating expenses | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $16.1B | |
| Operating expenses | $7.33B | $7.47B | $7.68B | $8.39B | $8.07B | $9.93B | $7.42B | $8.28B | $8.11B | $8.1B | |
| Operating income | $3.36B | $2.92B | $3.08B | $3.01B | $3.51B | $2.72B | $4.45B | $3.93B | $4.37B | $6.45B | |
| Interest income | $29M | $48M | $39M | $49M | $12M | $10M | $107M | $118M | $173M | $179M | |
| Interest expense | $308M | $283M | $264M | $249M | $217M | $178M | $248M | $243M | $256M | $247M | |
| Other non-operating income (gains on investments, FX ...) | -$3.84B | $2.4B | $2.2B | $1.62B | $8.33B | $617M | -$425M | -$105M | -$243M | $6M | |
| Total non-operating income | $3.53B | -$2.68B | -$2.47B | -$1.87B | -$8.54B | -$795M | $177M | -$138M | -$13M | -$253M | |
| Income before tax | $6.89B | $239M | $610M | $1.14B | -$5.03B | $1.93B | $4.63B | $3.79B | $4.36B | $6.2B | |
| Income tax | $1.61B | -$53M | $356M | $18M | -$695M | $636M | $905M | $629M | $878M | $1.1B | |
| Net income | $5.18B | $67M | $34M | $900M | -$4.54B | $1.11B | $3.56B | $3B | $3.3B | $4.76B | |
| EPS (basic) | $22.95 | $0.32 | $0.17 | $4.97 | -$27.02 | $7.31 | $25.23 | $22.54 | $25.86 | $38.55 | |
| EPS (diluted) | $22.73 | $0.32 | $0.17 | $4.95 | -$27.02 | $7.23 | $25.04 | $22.39 | $25.72 | $38.38 | |
| Shares (basic, weighted) | 221M | 208M | 196M | 181M | 161M | 152M | 141M | 133M | 127M | 124M | |
| Shares (diluted, weighted) | 223M | 209M | 197M | 182M | 161M | 154M | 142M | 134M | 128M | 124M | |
| Depreciation & amortization | $910M | $951M | $949M | $922M | $887M | $760M | $608M | $635M | $636M | $729M | |
| EBITDA | $8.11B | $1.47B | $1.82B | $2.32B | -$3.93B | $2.87B | $5.49B | $4.67B | $5.25B | $7.18B |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-K 2026-03-31, 10-Q 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-K 2025-03-31, 10-Q 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-01